References
- GilliesERFrechetJMDendrimers and dendritic polymers in drug deliveryDrug Discov Today2005101354315676297
- SampathkumarSGYaremaKJTargeting cancer cells with dendrimersChem Biol20051215615664507
- FangJNakamuraHMaedaHThe EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
- TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
- PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
- DuncanRIzzoLDendrimer biocompatibility and toxicityAdv Drug Deliv Rev200557152215223716297497
- LeeCCMacKayJAFrechetJMSzokaFCDesigning dendrimers for biological applicationsNat Biotechnol200523121517152616333296
- EsfandRTomaliaDAPoly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applicationsDrug Discov Today20016842743611301287
- MamedeMSagaTIshimoriTHepatocyte targeting of 111 In-labeled oligo-DNA with avidin or avidin-dendrimer complexJ Control Release200495113314115013240
- SvensonSTomaliaDADendrimers in biomedical applications – reflections on the fieldAdv Drug Deliv Rev200557152106212916305813
- ZhangYSunYXuXSynthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugatesJ Med Chem20105383262327220350006
- PillaiVCYesudasRShaikIHDelivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approachBioconjug Chem201021220320720063878
- VlasovGPLesinaEAKorol’kovVIOptimization of transfection properties of DNA-lysine dendrimer complexesBioorg Khim200531216717415889791
- ChoiJSParkJSSupramolecular self-assembly of poly(ethylene glycol)-block-poly (L-lysine) dendrimer with plasmid DNAMethods Mol Med200165233321318743
- FroehlichEMandevilleJSWeinertCMKreplakLTajmir-RiahiHABundling and aggregation of DNA by cationic dendrimersBiomacromolecules201112251151721192723
- FroehlichEMandevilleJSKreplakLTajmir-RiahiHAAggregation and particle formation of tRNA by dendrimersBiomacromolecules20111272780278721574643
- FroehlichEMandevilleJSArnoldDKreplakLTajmir-RiahiHAEffect of PEG and mPEG-anthracene on tRNA aggregation and particle formationBiomacromolecules201213128228722176277
- NavarroGTros de IlarduyaCActivated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivoNanomedicine20095328729719523431
- KuoJHLiouMJChiuHCEvaluating the gene-expression profiles of HeLa cancer cells treated with activated and nonactivated poly(amidoamine) dendrimers, and their DNA complexesMol Pharm20107380581420394435
- KandalaPKWrightSESrivastavaSKBlocking EGFR activation suppresses ovarian tumor growth in vitro and in vivoJ Pharmacol Exp Ther2012341243222205686
- FrederiksenKSAbrahamsenNCristianoRJDamstrupLPoulsenHSGene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptorCancer Gene Ther20007226226810770635
- ChenJGamouSTakayanagiAOhtakeYOhtsuboMShimizuNReceptor-mediated gene delivery using the Fab fragments of anti-epidermal growth factor receptor antibodies: improved immunogene approachCancer Gene Ther1998563573649917090
- YuanQLeeEYeudallWAYangHDendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug deliveryOral Oncol201046969870420729136
- SebastianSSettlemanJReshkinSJAzzaritiABellizziAParadisoAThe complexity of targeting EGFR signalling in cancer: from expression to turnoverBiochim Biophys Acta20061766112013916889899
- ThomasTPShuklaRKotlyarADendrimer-epidermal growth factor conjugate displays superagonist activityBiomacromolecules20089260360918193839
- ZhangQChenSZhuoRXZhangXZChengSXSelf-assembled terplexes for targeted gene delivery with improved transfectionBioconjug Chem201021112086209220931957
- KrugerJSReddyKBDistinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cellsMol Cancer Res200311180180914517342
- ShcharbinDPedziwiatrEBryszewskaMHow to study dendriplexes I: CharacterizationJ Control Release2009135318619719331857
- MounkesLCZhongWCipres-PalacinGHeathTDDebsRJProteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivoJ Bio Chem19982734026164261709748298
- MislickKABaldeschwielerJDEvidence for the role of proteoglycans in cation-mediated gene transferProc Natl Acad Sci U S A1996932212349123548901584
- TangMXRedemannCTSzokaFCJrIn vitro gene delivery by degraded polyamidoamine dendrimersBioconjug Chem1996767037148950489
- AndersonNGAhmadTChanKDobsonRBundredNJZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the ngrowth of EGFR-positive cancer cell lines with or without erbB2 overexpressionInt J Cancer200194677478211745477
- DuncanRPolymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway?Pharm Sci Technolo Today199921144144910542390
- ZelphatiOUyechiLSBarronLGSzokaFCJrEffect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cellsBiochim Biophys Acta1998139021191339507083